Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome—Polish Adult Leukemia Group (PALG) pilot study

✍ Scribed by Jerzy Hołowiecki; Sebastian Grosicki; Sławomira Kyrcz-Krzemien; Aleksander B. Skotnicki; Beata Piatkowska-Jakubas; Krzysztof Warzocha; Ilona Seferynska; Barbara Zdziarska

• Publisher: Springer
• Year: 2007
• Tongue: English
• Weight: 206 KB
• Volume: 87
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-007-0421-4